Skip to content
Dosage GuideResearch Reference

Amylin Dosage

Research-based dosing protocols, timing guidance, and reconstitution reference for Amylin. All information is for educational purposes only.

Quick Answer

Amylin itself is not directly dosed due to aggregation issues. Pramlintide, a synthetic amylin analog, is administered subcutaneously at 60–120 mcg before major meals. It’s crucial to reduce mealtime insulin by 50% upon initiation to prevent hypoglycemia. Native amylin is sometimes used in research at 10–50 mcg doses.

→ Amylin Benefits→ Amylin Side Effects→ Full Amylin Profile
Table of Contents

Standard Dosage Range

Research dosing range: 60-120 mcg (pramlintide)

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Type 1 or Type 2 Diabetes (pramlintide)

60–120 mcgBefore major meals (2–3× daily)
Duration

Ongoing (chronic management)

Administer subcutaneously immediately before meals. Reduce mealtime insulin dose by 50% at initiation. Titrate pramlintide dose as tolerated.

Postprandial Glucose Control (pramlintide)

60–120 mcgBefore meals with high carbohydrate content
Duration

As needed

Adjust dose based on individual response and carbohydrate content of the meal. Monitor blood glucose levels closely.

Research Studies (native amylin)

10–50 mcgSingle dose or short-term infusion
Duration

Single administration

Native amylin is used in research settings to study its physiological effects. Not suitable for chronic administration due to fibril formation risk.

Timing & Frequency

Pramlintide should be injected immediately before meals. The timing is crucial because amylin works in concert with insulin to regulate postprandial glucose levels. Administering too early or too late may lead to suboptimal glucose control or increased risk of hypoglycemia.

Cycle Guidance

Pramlintide is typically used as a chronic medication for diabetes management, not a cycled therapy. Discontinuation may lead to worsening glucose control. Consult a physician before making any changes to your medication regimen.

Reconstitution Reference

Quick reference for reconstituting Amylin. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial SizeN/A (pre-filled pens for pramlintide)
BAC Water VolumeN/A
Concentration & DrawN/A
StorageStore pramlintide pens in the refrigerator until first use. After first use, pens can be stored at room temperature for up to 30 days.
StabilitySee manufacturer’s instructions for specific stability information.
Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What is the proper pramlintide dosage?
The typical starting dose of pramlintide is 60 mcg injected subcutaneously before major meals. The dose may be titrated up to 120 mcg as tolerated. It's crucial to reduce mealtime insulin by 50% when starting pramlintide to prevent hypoglycemia.
How does pramlintide work?
Pramlintide is a synthetic analog of amylin that slows gastric emptying, suppresses glucagon secretion, and promotes satiety, all of which help to regulate postprandial glucose levels. It complements the actions of insulin in managing diabetes.
Can pramlintide be used in combination with other diabetes medications?
Pramlintide is often used in combination with insulin, but it should not be mixed in the same syringe. It can also be used with other oral diabetes medications, but caution is advised due to the increased risk of hypoglycemia.
What should I do if I miss a dose of pramlintide?
If you miss a dose of pramlintide, skip the missed dose and take your next dose before your next major meal. Do not double the dose to catch up.
How long does it take for pramlintide to start working?
Pramlintide starts working soon after injection, helping to slow gastric emptying and regulate postprandial glucose levels. The effects are noticeable within 30 minutes to an hour after injection.

References

  1. 1
    Amylin: physiology, pharmacology, and clinical potential for the treatment of obesity and diabetes(2015)PubMed ↗
  2. 2
    Amylin and its analogs: physiology, pharmacology, and therapeutic potential in diabetes and obesity(2011)PubMed ↗
  3. 3
    Pramlintide in the treatment of diabetes mellitus(2006)PubMed ↗

Last updated: 2026-02-19